AOD-9604
GH fragment
A GH-fragment weight-loss compound that keeps showing up in fat-loss research and protocol-driven search demand.

How It Works
AOD-9604 is designed to focus on the fat-mobilization side of growth-hormone signaling without reproducing the full endocrine profile of HGH.
Practical Information
injection
AOD-9604 is often marketed as an injectable protocol compound, but practical coverage should separate that market format from the more limited human evidence base.
oral
Oral AOD-9604 matters because human study history includes oral administration, even though consumer search demand often drifts toward injectable peptide-market protocols.
Related Articles
See all 2 articles →AOD-9604 Dosage: What Human Trials Really Showed
The AOD-9604 dosage question is clearest when you stick to clinical evidence: once-daily oral regimens in real human trials, followed by a larger study that changed everything. Here's what actually moved the needle.
4 min read
AOD-9604: What It Promises for Fat-Loss Progress
AOD-9604 keeps showing up because the idea is attractive: a narrower fat-loss peptide with less of the GLP-1 routine and a lower out-of-pocket barrier. This guide explains what it is, what the human evidence actually shows, and why the price-and-proof picture still keeps it on the fringe.
4 min read
